Background
• 5-year survival for VVM is inferior to CM
• CM – 92%
• Vulvar – 58%
• Vaginal 27%
• Current therapeutic strategies for vulvar and vaginal melanoma (VVM) mimic those of cutaneous melanoma (CM)
Publications
Too much skin in the game a paradigm shift in our understanding of vulvar and vaginal melanomas as distinct tumor types compared with cutaneous melanomas
– Caris Life Sciences